Iconovo - Asset Resilience Ratio
Iconovo (ICO) has an Asset Resilience Ratio of 3.76% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Iconovo carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Iconovo's Asset Resilience Ratio has changed over time. See ICO net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Iconovo's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ICO company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr4.93 Million | 3.76% |
| Total Liquid Assets | Skr4.93 Million | 3.76% |
Asset Resilience Insights
- Limited Liquidity: Iconovo maintains only 3.76% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Iconovo Industry Peers by Asset Resilience Ratio
Compare Iconovo's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for Iconovo (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Iconovo.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 3.76% | Skr4.93 Million ≈ $530.44K |
Skr131.08 Million ≈ $14.11 Million |
+0.28pp |
| 2024-12-31 | 3.48% | Skr5.07 Million ≈ $545.51K |
Skr145.69 Million ≈ $15.68 Million |
-14.75pp |
| 2023-12-31 | 18.22% | Skr23.34 Million ≈ $2.51 Million |
Skr128.08 Million ≈ $13.78 Million |
+7.14pp |
| 2022-12-31 | 11.09% | Skr13.45 Million ≈ $1.45 Million |
Skr121.27 Million ≈ $13.05 Million |
-52.82pp |
| 2021-12-31 | 63.91% | Skr94.94 Million ≈ $10.22 Million |
Skr148.54 Million ≈ $15.99 Million |
+2.86pp |
| 2020-12-31 | 61.05% | Skr61.69 Million ≈ $6.64 Million |
Skr101.04 Million ≈ $10.87 Million |
-17.33pp |
| 2019-12-31 | 78.38% | Skr89.16 Million ≈ $9.59 Million |
Skr113.75 Million ≈ $12.24 Million |
+5.41pp |
| 2018-12-31 | 72.97% | Skr53.05 Million ≈ $5.71 Million |
Skr72.70 Million ≈ $7.82 Million |
+19.58pp |
| 2017-12-31 | 53.39% | Skr22.48 Million ≈ $2.42 Million |
Skr42.10 Million ≈ $4.53 Million |
-3.99pp |
| 2016-12-31 | 57.39% | Skr11.54 Million ≈ $1.24 Million |
Skr20.11 Million ≈ $2.16 Million |
-- |
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more